MDxHealth, Inc. Secures Agreement With Prime Health Services PPO Network Providing Increased Access To Confirmmdx For Prostate Cancer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif. and HERSTAL, Belgium, Feb. 20, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to improve the diagnosis and treatment of cancer patients, today announced that it has signed an agreement with Prime Health Services, Inc. ("Prime Health") a Preferred Provider Organization (PPO) network. This agreement covers all 50 states, offering patients greater access to MDxHealth's ConfirmMDx® for Prostate Cancer test. This agreement extends ConfirmMDx for Prostate Cancer testing to approximately 144 million covered lives throughout the U.S.

Help employers find you! Check out all the jobs and post your resume.

Back to news